Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 15, 2013

Agilent to Restructure, Laying off 450

  • Announcing its second-quarter financial results yesterday, Agilent said it plans to lay off around 450 employees—2% of the company’s global workforce—in a restructuring move. Further details about the timing and scope of such workforce reductions were not disclosed.

    Reporting on his firm’s second quarter financials, in a statement Agilent CEO Bill Sullivan said: “We expect the macroeconomic environment to remain challenging throughout the second half of 2013 and are taking additional actions to strengthen our operating performance."



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »